192 related articles for article (PubMed ID: 29119941)
1. Targeting of Inflammation for Radiation Protection and Mitigation.
Yahyapour R; Amini P; Rezapoor S; Rezaeyan A; Farhood B; Cheki M; Fallah H; Najafi M
Curr Mol Pharmacol; 2018; 11(3):203-210. PubMed ID: 29119941
[TBL] [Abstract][Full Text] [Related]
2. NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.
Mortezaee K; Goradel NH; Amini P; Shabeeb D; Musa AE; Najafi M; Farhood B
Curr Mol Pharmacol; 2019; 12(1):50-60. PubMed ID: 30318012
[TBL] [Abstract][Full Text] [Related]
3. COX-2 in Radiotherapy: A Potential Target for Radioprotection and Radiosensitization.
Cheki M; Yahyapour R; Farhood B; Rezaeyan A; Shabeeb D; Amini P; Rezapoor S; Najafi M
Curr Mol Pharmacol; 2018; 11(3):173-183. PubMed ID: 29468988
[TBL] [Abstract][Full Text] [Related]
4. [Radiation-induced bystander effect: the important part of ionizing radiation response. Potential clinical implications].
Wideł M; Przybyszewski W; Rzeszowska-Wolny J
Postepy Hig Med Dosw (Online); 2009 Aug; 63():377-88. PubMed ID: 19724078
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy.
Yahyapour R; Motevaseli E; Rezaeyan A; Abdollahi H; Farhood B; Cheki M; Najafi M; Villa V
Curr Radiopharm; 2018; 11(1):34-45. PubMed ID: 29284398
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications.
Najafi M; Motevaseli E; Shirazi A; Geraily G; Rezaeyan A; Norouzi F; Rezapoor S; Abdollahi H
Int J Radiat Biol; 2018 Apr; 94(4):335-356. PubMed ID: 29504497
[TBL] [Abstract][Full Text] [Related]
7. Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Shabeeb D; Musa AE; Fallah H; Najafi M
J Cell Commun Signal; 2019 Mar; 13(1):3-16. PubMed ID: 29911259
[TBL] [Abstract][Full Text] [Related]
8. Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy.
Farhood B; Mortezaee K; Goradel NH; Khanlarkhani N; Salehi E; Nashtaei MS; Najafi M; Sahebkar A
J Cell Physiol; 2019 May; 234(5):5728-5740. PubMed ID: 30317564
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review.
Lorimore SA; Wright EG
Int J Radiat Biol; 2003 Jan; 79(1):15-25. PubMed ID: 12556327
[TBL] [Abstract][Full Text] [Related]
10. Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics.
Yahyapour R; Motevaseli E; Rezaeyan A; Abdollahi H; Farhood B; Cheki M; Rezapoor S; Shabeeb D; Musa AE; Najafi M; Villa V
Clin Transl Oncol; 2018 Aug; 20(8):975-988. PubMed ID: 29318449
[TBL] [Abstract][Full Text] [Related]
11. Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.
Mortezaee K; Shabeeb D; Musa AE; Najafi M; Farhood B
Curr Clin Pharmacol; 2019; 14(1):41-53. PubMed ID: 30360725
[TBL] [Abstract][Full Text] [Related]
12. Bystander effect induced by UV radiation; why should we be interested?
Widel M
Postepy Hig Med Dosw (Online); 2012 Nov; 66():828-37. PubMed ID: 23175338
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy.
Rzeszowska-Wolny J; Przybyszewski WM; Widel M
Eur J Pharmacol; 2009 Dec; 625(1-3):156-64. PubMed ID: 19835860
[TBL] [Abstract][Full Text] [Related]
14. Melatonin as an anti-inflammatory agent in radiotherapy.
Najafi M; Shirazi A; Motevaseli E; Rezaeyan AH; Salajegheh A; Rezapoor S
Inflammopharmacology; 2017 Aug; 25(4):403-413. PubMed ID: 28255737
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory Signaling in a 3D Organotypic Skin Model after Low LET Irradiation-NF-κB, COX-2 Activation, and Impact on Cell Differentiation.
Acheva A; Schettino G; Prise KM
Front Immunol; 2017; 8():82. PubMed ID: 28239377
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the immune system to bystander and non-targeted effects of ionizing radiation.
Rödel F; Frey B; Multhoff G; Gaipl U
Cancer Lett; 2015 Jan; 356(1):105-13. PubMed ID: 24139966
[TBL] [Abstract][Full Text] [Related]
17. Responses to ionizing radiation mediated by inflammatory mechanisms.
Mukherjee D; Coates PJ; Lorimore SA; Wright EG
J Pathol; 2014 Feb; 232(3):289-99. PubMed ID: 24254983
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies.
Gandhi S; Chandna S
Cancer Metastasis Rev; 2017 Jun; 36(2):375-393. PubMed ID: 28707199
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin-2 modulates radiation-induced intestinal crypt progenitor/stem cell injury.
Liu Z; Tian H; Jiang J; Yang Y; Tan S; Lin X; Liu H; Wu B
Cell Death Differ; 2016 Sep; 23(9):1529-41. PubMed ID: 27128598
[TBL] [Abstract][Full Text] [Related]
20. Commentary on radiation-induced bystander effects.
Wright EG
Hum Exp Toxicol; 2004 Feb; 23(2):91-4. PubMed ID: 15070067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
